201 related articles for article (PubMed ID: 16207650)
1. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
Cuerda C; Zugasti A; Bretón I; Camblor M; Miralles P; García P
Nutr Clin Pract; 2005 Feb; 20(1):93-7. PubMed ID: 16207650
[TBL] [Abstract][Full Text] [Related]
2. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss.
Batterham MJ; Garsia R
Int J Androl; 2001 Aug; 24(4):232-40. PubMed ID: 11454075
[TBL] [Abstract][Full Text] [Related]
3. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
[TBL] [Abstract][Full Text] [Related]
5. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
[TBL] [Abstract][Full Text] [Related]
6. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
[TBL] [Abstract][Full Text] [Related]
7. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials update in human immunodeficiency virus wasting.
Muurahainen N; Mulligan K
Semin Oncol; 1998 Apr; 25(2 Suppl 6):104-11. PubMed ID: 9625392
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
Saha B; Rajadhyaksha GC; Ray SK
J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
[TBL] [Abstract][Full Text] [Related]
10. Megestrol acetate: promises and pitfalls.
Farrar DJ
AIDS Patient Care STDS; 1999 Mar; 13(3):149-52. PubMed ID: 10375262
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the AIDS Wasting Syndrome.
Corcoran C
Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
[TBL] [Abstract][Full Text] [Related]
13. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
Sattler FR; Jaque SV; Schroeder ET; Olson C; Dube MP; Martinez C; Briggs W; Horton R; Azen S
J Clin Endocrinol Metab; 1999 Apr; 84(4):1268-76. PubMed ID: 10199766
[TBL] [Abstract][Full Text] [Related]
15. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.
Van Loan MD; Strawford A; Jacob M; Hellerstein M
AIDS; 1999 Feb; 13(2):241-8. PubMed ID: 10202830
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.
Sardar P; Jha A; Roy D; Majumdar U; Guha P; Roy S; Banerjee R; Banerjee AK; Bandyopadhyay D
HIV Clin Trials; 2010; 11(4):220-9. PubMed ID: 20974577
[TBL] [Abstract][Full Text] [Related]
17. [Suprarenal insufficiency associated with megestrol acetate in an HIV patient].
Ibarra Barrueta O; García García M; Aguirre Gómez C; Mayo Suárez J
Farm Hosp; 2009; 33(2):115-6. PubMed ID: 19480803
[No Abstract] [Full Text] [Related]
18. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
Navarro JF; Mora C; Macía M; García J
Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
[TBL] [Abstract][Full Text] [Related]
19. [Megestrol in the treatment of AIDS associated cachexia. Evaluation by bioelectric impedance analysis of body composition].
Pérez De Oteyza C; García Cortés A; Menéndez Martínez MA; Torres Léon JM; Pérez Aznar C; Carnicero Bujarrabal M
An Med Interna; 1998 May; 15(5):255-8. PubMed ID: 9629772
[TBL] [Abstract][Full Text] [Related]
20. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.
Beller E; Tattersall M; Lumley T; Levi J; Dalley D; Olver I; Page J; Abdi E; Wynne C; Friedlander M; Boadle D; Wheeler H; Margrie S; Simes RJ
Ann Oncol; 1997 Mar; 8(3):277-83. PubMed ID: 9137798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
